Gowling WLG advised ITM on the Joint Venture. ITM Isotope Technologies Munich SE (“ITM”), a leading radiopharmaceutical biotech company, and Canadian Nuclear Laboratories (“CNL”), the manager...
Standard 1 Year Membership Required
You must be a Standard 1 Year member to access this content.
Already a member? Log in here
